Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Mar;38(3):757-762.
doi: 10.1007/s00467-022-05687-y. Epub 2022 Jul 21.

Clinical and pathological investigation of oligomeganephronia

Hideaki Kitakado  1 , Tomoko Horinouchi  2 , Chika Masuda  1 , Atsushi Kondo  1 , Sadayuki Nagai  1 , Yuya Aoto  1 , Nana Sakakibara  1 , Takeshi Ninchoji  1   3 , Norishige Yoshikawa  4 , Kandai Nozu  1
Affiliations

Clinical and pathological investigation of oligomeganephronia

Hideaki Kitakado et al. Pediatr Nephrol. 2023 Mar.

Abstract

Background: Oligomeganephronia (OMN) is a rare congenital anomaly involving the kidney and urinary tract, characterized by decreased number and compensatory hypertrophy of the nephron. It is caused by abnormal kidney development during the embryonic period, especially in patients with low birth weight; however, the actual etiology and clinical features remain unknown. We aim to reveal the clinical and pathological characteristics, treatment, and outcome.

Methods: Ten patients diagnosed with OMN between 2013 and 2020 were retrospectively investigated. The data were presented as the median ± interquartile range, and statistical significance was set at p < 0.05.

Results: The age at diagnosis was 14.1 years, the male-to-female ratio was 6:4, and only four cases were born with low birth weight. The estimated glomerular filtration rate (eGFR) was 62.2 mL/min/1.73 m2. The glomerulus diameter of OMN patients was significantly larger (217 vs. 154 µm, p < 0.001) in OMN patients, and the number of glomeruli of OMN patients was lower (0.89 vs. 2.05/mm2, p < 0.001) than the control group. Eight of the ten cases were identified by urinary screening. Nine patients were treated with renin-angiotensin system (RAS) inhibitors, following which proteinuria successfully decreased or disappeared. Their median eGFR was also stable, 53.3 mL/min/1.73 m2.

Conclusions: As few symptoms can lead to OMN discovery, most patients were found during urine screening at school. Kidney dysfunction was observed in all patients at the time of kidney biopsy. Proteinuria has been significantly reduced and the decline rate of eGFR might be improved by RAS inhibitors. "A higher resolution version of the Graphical abstract is available as Supplementary information".

Keywords: Congenital anomalies of the kidney and urinary tract; Kidney hypoplasia; Oligomeganephronia; Screening.

PubMed Disclaimer

References

    1. Hopkins K, Mowry J, Houghton D (2013) Congenital oligomeganephronia: computed tomography appearance. Clin Pract 3:e31. https://doi.org/10.4081/cp.2013.e31 - DOI
    1. Adelman RD, Shapiro S (1977) Bilateral renal hypoplasia with oligomeganephronia. Urology 9:571–575. https://doi.org/10.1016/0090-4295(77)90259-x - DOI
    1. Broyer M, Soto B, Gagnadoux MF, Adi M, Rica C, Gubler MC (1997) Oligomeganephronic renal hypoplasia. Adv Nephrol Necker Hosp 26:47–63
    1. Rennke HG, Klein PS (1989) Pathogenesis and significance of nonprimary focal and segmental glomerulosclerosis. Am J Kidney Dis 13:443–456. https://doi.org/10.1016/s0272-6386(89)80001-0 - DOI
    1. Alexander BT (2003) Intrauterine growth restriction and reduced glomerular number: role of apoptosis. Am J Physiol Regul Integr Comp Physiol 285:R933-934. https://doi.org/10.1152/ajpregu.00446.2003 - DOI

Substances

LinkOut - more resources